Navigating Drug Pricing, Policy, and Access with Coral Partner Alison Falb
About this episode
Meg Koepke interviews Alison Falb about drug pricing, policy trends, and access challenges in the life sciences sector.
In this episode, Coral’s Founder Meg Koepke talks with Alison Falb about her journey from CMS to FDA to Coral. We explore current policy trends and challenges in Life Sciences –what they mean for organizations navigating drug pricing reforms, coverage, and access challenges.
More episodes of Pop Health Podcast
- Reimagining Post-Acute Care: Why the Future of Recovery Happens at Home
- From Concept to Model: The Making of LEAD
- Primary Care Population-Based Payment and Value Based Payment State Lessons
- What the LEAD Model Means for ACOs and the Future of Value-Based Care
- New Model Mania: Unpacking CMS's RHTP, ASM, LEAD, ACCESS, and ELEVATE
- Rural Health Transformation: How States Can Align Stakeholders for Lasting Change
Explore listener stats, chart rankings, contacts and more on the Pop Health Podcast podcast page.